The combination of medication delivery technology and nanotechnology is a significant change in drug development. We explore this interaction in our study. This beneficial relationship gains traction as green synthesis improves cost-effectiveness, safety, and environmental sustainability. As we delve deeper into this collaboration, traditional medical research approaches change, leading to a more refined approach to therapeutic innovation. The integration of nanotechnology, across various disciplines, plays a crucial role in creating nanomaterials within a specific size range. These nanoparticles have unique advantages, such as improved bioavailability, controlled medication release, and targeted administration, addressing issues with medication solubility and stability. The combination of nanoscience and biogenic materials has renewed the use of natural plant chemicals in medicine development. Nanotechnology methods like liposomes and micelles guarantee precise and controlled release mechanisms, addressing concerns about toxicity and biocompatibility. Green nanotechnology, following green chemistry principles, focuses on the environmentally friendly creation of nanoparticles using plant extracts as alternatives to conventional chemical procedures. This approach is versatile and can be used in areas such as environmental remediation, medicine, and catalysis. Plant-derived nanoparticles (PDNPs) with different compositions, including metal oxides, polymers, silver, gold, and copper, show promise in industries like electronics and agriculture. This strategic alignment meets sustainability goals and emphasizes scalability, environmental responsibility, and reduced ecological impact. A deep understanding of nanotechnology-based drug delivery principles is essential for exploring therapeutic applications. Precise drug targeting, controlled release, and improved drug solubility have the potential to effectively manage various medical conditions. However, further research is necessary to address long-term efficacy, safety, and production costs. The chapter examines the merging of medicine delivery systems and nanotechnology, which is a groundbreaking advancement in medical technology. Nanotechnology-based drug delivery systems have the potential to transform health care by providing personalized and environmentally friendly treatment options for various medical conditions.